Skip to content
Search

Latest Stories

Kartik Aaryan, Tabu and Kiara Advani starrer Bhool Bhulaiyaa 2 to hit the big screens in November 2021

Kartik Aaryan, Tabu and Kiara Advani starrer Bhool Bhulaiyaa 2 to hit the big screens in November 2021

By Murtuza Iqbal

For the past few days, filmmakers have been announcing the release date of their movies, and Kartik Aaryan was a bit upset as no release date of his movies was being announced. The actor had posted on Instagram, “Meri koi release date announce nahi ho rahi kya.”


But now, finally, the release date of a Kartik starrer has been announced. Bhool Bhulaiyaa 2 will hit the big screens on 19th November 2021.

T-Series took to Instagram to make an announcement about the film. They posted, “The edge-of-the seat comedy psychological thriller starring Kartik Aaryan, Tabu and Kiara Advani will release in theatres on 19th November 2021. Produced by Bhushan Kumar, Murad Khetani and Krishan Kumar under the banner of T-Series and Cine 1 Studios, the film is directed by Anees Bazmee & written by Farhad Samji and Aakash Kaushik. #BhoolBhulaiyaa2 @kartikaaryan @kiaraaliaadvani @tabutiful #BhushanKumar @muradkhetani #KrishanKumar @tseriesfilms @tseries.official @cine1studios @aneesbazmee @farhadsamji @ipritamofficial #AakashKaushik @bhoolbhulaiyaa2movie.”

Directed by Anees Bazmee, Bhool Bhulaiyaa 2 also stars Tabu and Kiara Advani in the lead roles. The music of the film is composed by Pritam who had also composed songs for the first instalment.

The track Mere Dholna from Bhool Bhulaiyaa is still remembered, and there were reports that Tabu will be dancing on the recreated version of the track in Bhool Bhulaiyaa 2.

More For You

pharmacy

The UK spends just 9 per cent of healthcare budgets on medicines while patients face growing access gaps.

iStock

UK calls for new pharmaceutical investment to strengthen life sciences

Highlights

  • UK life sciences sector contributed £17.6bn GVA in 2021 and supports 126,000 high-skilled jobs.
  • Inward life sciences FDI fell by 58 per cent from £1,897m in 2021 to £795m in 2023.
  • Experts warn NHS underinvestment and NICE pricing rules are deterring innovation and patient access.

Investment gap

Britain is seeking to attract new pharmaceutical investment as part of its plan to strengthen the life sciences sector, Chancellor Rachel Reeves said during meetings in Washington this week. “We do need to make sure that we are an attractive place for pharmaceuticals, and that includes on pricing, but in return for that, we want to see more investment flow to Britain,” Reeves told reporters.

Recent ABPI report, ‘Creating the conditions for investment and growth’, The UK’s pharmaceutical industry is integral to both the country’s health and growth missions, contributing £17.6 billion in direct gross value added (GVA) annually and supporting 126,000 high-skilled jobs across the nation. It also invests more in research and development (R&D) than any other sector. Yet inward life sciences foreign direct investment (FDI) fell by 58per cent, from £1,897 million in 2021 to £795 million in 2023, while pharmaceutical R&D investment in the UK lagged behind global growth trends, costing an estimated £1.3 billion in lost investment in 2023 alone.

Keep ReadingShow less